As of June 5, 2025, Osprey Medical Inc (OSP.AX) reports a Gross Margin of 35.98%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Osprey Medical Inc's Gross Margin
Over recent years, Osprey Medical Inc's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2021-12-31 | 35.98% |
| 2020-12-31 | 26.81% |
| 2019-12-31 | 51.77% |
| 2018-12-31 | 44.94% |
| 2017-12-31 | 14.53% |
This steady improvement highlights how Osprey Medical Inc manages its operational efficiency and pricing power over time.
Comparing Osprey Medical Inc's Gross Margin to Peers
To better understand Osprey Medical Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Osprey Medical Inc (OSP.AX) | 35.98% |
| Simavita Ltd (SVA.AX) | 5584.01% |
| Silver Castle Holdings Ltd (ICB.TA) | 2512.20% |
| Neurotech International Ltd (NTI.AX) | 100.00% |
| Vitasora Health Ltd (RSH.AX) | 99.63% |
| CardieX Ltd (CDX.AX) | 92.68% |
Compared to its competitors, Osprey Medical Inc's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.